Inactive Instrument

News Zomedica Corp. Toronto S.E.

Equities

ZOM

CA98980M1095

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA Diagnostic Platform	03/05	AQ
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET	01/05	AQ
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024	10/04	AQ
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Zomedica Seeks Acquisitions	02/04	CI
Transcript : Zomedica Corp., Q4 2023 Earnings Call, Apr 01, 2024	02/04
Earnings Flash (ZOM) ZOMEDICA Posts Q4 Revenue $7.3M	02/04	MT
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024	02/04	CI
Zomedica Announces Publication of Research Concluding TRUFORMA Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay Platform	15/03	AQ
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform	14/03	CI
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences	13/03	AQ
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs	08/03	AQ
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024	06/03	AQ
Transcript : Zomedica Corp. - Shareholder/Analyst Call	28/02
Transcript : Zomedica Corp. - Analyst/Investor Day	14/02
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences	09/02	AQ
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET	07/02	AQ
Open Letter to Zomedica Shareholders from your Chief Executive Officer	01/02	AQ
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference	31/01	AQ
Zomedica Pharmaceuticals Reports Preliminary Q4 Revenue	18/01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zomedica Corp. Toronto S.E.

Equities

ZOM

CA98980M1095

Summary

Filters